Top-News

InnoCan Pharma: Biotech-Innovation auf FDA-Kurs!(Anzeige)

Kazia Therapeutics News

Aktie

WKN: A2H8QW ISIN: AU000000KZA9

Keine aktuellen Kursdaten verfügbar

Handeln Depot/Watchlist

Dieses Wertpapier ist nicht mehr handelbar.

Aktienanzahl *

163,41 Mio.

Marktkapitalisierung *

-

Streubesitz

-

Index-Zugehörigkeit

-

IR-Website

*Stand: 10.12.2022

Kazia Therapeutics News

06.12.22 - DGAP

EQS-News: Kazia Therapeutics talks positive pre-clinical data for EVT801

EQS-News: Kazia Therapeutics Ltd Kazia Therapeutics talks positive pre-clinical data for EVT801 06.12.2022 / 17:45 CET/CEST The issuer is solely responsible for the content of ...

07.09.22 - ACCESSWIRE

Kazia Therapeutics (KZIA): Doubling Down on Clinical Development

LONDON, UK / ACCESSWIRE / September 7, 2022 / Kazia Therapeutics' FY22 results recapped a busy year focused on strengthening its oncology-focused pipeline. While the year ...

03.06.21 - PR Newswire

Kazia Therapeutics to Present at LD Micro Invitational XI

Kazia Therapeutics to Present at LD Micro Invitational XI PR Newswire

02.09.20 - DGAP

Edison Investment Research Limited: Edison issues ADR outlook on Kazia Therapeutics (KZIA)

Edison Investment Research Limited Edison Investment Research Limited: Edison issues ADR outlook on Kazia Therapeutics (KZIA) 02-Sep-2020 / 15:05 GMT/BST London, UK, 2 ...

23.06.19 - ACCESSWIRE

Edison issues ADR outlook on Kazia Therapeutics (KZIA)

LONDON, UK / ACCESSWIRE / June 23, 2019 / Kazia Therapeutics (ASX: KZA) has identified a higher maximum tolerated dose (MTD) from a Phase IIa study of its brain-penetrant ...

Newssuche

Videos

03.05.24 -13,45%

Technical Trading: Gold freitags Long

Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Neuer Gesetzesentwurf

Cannabisaktien sollten nun den S&P um 60% outperformen!
weiterlesen»

Anzeige